Controversial Discussion: Vaccination for Chikungunya Disease Remains Un Certain
In this local pharmacy, there are still stocks of the Ixchiq vaccine, yet it's uncertain if they'll be administered. A youthful lady confesses, "It's supposed to save lives, not take them." A bystander calmly asserts, "There might be side effects." Regrettably, the Ixchiq vaccine has claimed one life and caused severe side effects in individuals over 80 years old (New window). Consequently, vaccination for those aged 65 and above has been temporarily halted.
Some Have Faith in Vaccination
"Medicine is intended to heal. If there are serious side effects, it's right to reevaluate with experts.", asserts the President of the Pharmacy Order of Réunion-Mayotte. However, in Réunion, the virus is a menace, so some aren't hesitant. "We must continue to have faith.", states a mother. "I got it for COVID; if I have to, I'll do it again.", assures a passerby. Vaccination remains available for those aged 18-64 with comorbidities.
Common side effects of the Ixchiq vaccine may include injection site tenderness, headache, fatigue, muscle and joint pain, fever, and nausea. However, specific frequencies for individuals over 65 weren't provided in the searched reports (2, 5). Moreover, there have been reports of severe adverse events, particularly among elderly individuals with underlying conditions (4). The vaccine is contraindicated for immunocompromised individuals and carries a risk of serious or prolonged chikungunya-like reactions as well as fainting upon administration. The vaccine label includes warnings about these risks, affecting all age groups (5).
Despite these concerns, the Advisory Committee on Immunization Practices (ACIP) recommends offering the vaccine to individuals aged 65 and above with underlying health conditions if they have moderate exposure to mosquitoes, especially in areas with past transmission of the virus (5). In conclusion, while the vaccine can offer protection against chikungunya, the decision to use it in older adults with health issues should be made carefully, weighing both the potential benefits and risks. Watch the full report in the video above.
A science-minded individual might suggest, "Given the health-and-wellness benefits of vaccines, it's crucial to consider the risks, especially in those over 65 who may have comorbidities." Meanwhile, an optimistic citizen echoes, "Vaccines meant to protect us shouldn't scare us; they are stored in refrigerators for a reason - they're vital to social health." However, a concerned gerontologist might caution, "It's essential to remember that not everyone responds the same way to a vaccine and side effects, even severe ones, have been noted in the elderly population." Lastly, a local health department representative might declare, "As per the guidelines, vaccination remains accessible for individuals aged 18-64 with pre-existing health conditions, emphasizing the importance of evaluating personal risks and benefits before making a decision."
